Of ivermectin

The activity of ivermectin against the filarial parasite Dirofilaria immitis in dogs suggested a possible role for the control of filarial parasites of humans (20). It has been extensively tested in human onchocerciasis and is now considered to be the dmg of choice. In a single yearly oral dose, it suppresses microfilariae in the skin and eyes and, in most cases, prevents the progression of the disease to blindness. Table 4 shows the results of a 30-patient double-blind study recorded over one year. 

Ten patients received a single oral dose of ivermectin, 12 mg. 

Table 5. Efficacy of Ivermectin in the Treatment of Wuchereria Filariasis...

Fig. 4. Treatment of ivermectin with methanolic potassium hydroxide solution (25).

The average daily release rate of ivermectin increases modestly during the steady-state period. This is most likely the result of a combination of factors... 

DG Pope, PK Wilkinson, JR Egerton, J Conroy. Oral controlled release delivery of ivermectin in cattle via an osmotic pump. J Pharm Sci 74 1108-1110, 1985. 

B Eckenhoff, R Cortese, JC Wright, PK Wilkinson, JR Zingerman, DG Pope. Os-motically-driven ruminal delivery system for the long term rate controlled delivery of ivermectin. Pharm Res (Suppl)4 46, 1987. 

Zeng Z, Andrew NW, Arison BH, Luf-fer-Atlas D, Wang RW. Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver chromosomes. Xenobiotica 1998 28 313-321. 

Holbrook, F.R. and Mullens, B.A. Effects of ivermectin on survival, fecundity, and egg fertility in Culicoides variipennis (Diptera Certaopogonidae), / Am. Mosq. Control Assoc., 10(1) 70-73, 1994. 

E. TPE is caused by microfilariae in the lungs and hyperimmune responsiveness to bancroftian or malayan filariasis. Paroxysmal respiratory symptoms may fluctuate in severity. Eosinophilia, almost always present, is usually very high, and the absence of microfilariae in the blood does not rule out TPE. A presumptive clinical diagnosis can be made by response to therapy without a lung biopsy. Diethylcarbamazine for 14 days is an effective therapy that can be repeated if symptoms persist. The role of ivermectin in TPE has not been established. 

Gunn A. and J.W. Sadd (1994). The effect of ivermectin on the survival, behavior and cocoon production of the earthworm Eisenia foetida. Pedobiologia 38 327-333. 

Following the oral administration of ivermectin, peak plasma concentration is achieved in four hours. Ivermectin is absorbed well on an empty stomach. The bioavailability is 50 to 60%. It is mainly metabolized in the liver and the tissue concentration is maximum in liver and fat. Ivermectin and its metabolites are excreted mainly in faeces. 

Treatment is with a single oral dose of ivermectin, 150 mcg/kg, with water on an empty stomach. Doses are repeated regimens vary from monthly to less frequent (every 6-12 months) dosing schedules. After acute therapy, treatment is repeated at 12-month intervals until the adult worms die, which may take 10 years or longer. With the first treatment only, patients with microfilariae in the cornea or anterior chamber may be treated with corticosteroids to avoid... 

Ivermectin also now plays a key role in onchocerciasis control. Annual mass treatments have led to major reductions in disease transmission. However, evidence of diminished responsiveness after mass administration of ivermectin has raised concern regarding selection of drug-resistant parasites. 

It is best to avoid concomitant use of ivermectin and other drugs that enhance GABA activity, eg, barbiturates, benzodiazepines, and valproic acid. Ivermectin should not be used during pregnancy. Safety in children younger than 5 years has not been established. 

Osei-Atweneboana MY Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana A two-phase epidemiological study. Lancet 2007 369 2021. [PMID 17574093]... 

Brain, R.A., Wilson, C., Johnson, D., Bryning, G., Peregrine, A.S., Boxall, A. and Solomon, K.R. (2007) Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms. Aquat Toxicol, 85, 229-240. 

The pharmacokinetics of ivermectin differ with the animal species, formulation, and the route of administration (50). When goats were given a subcutaneous administration of 0.2 mg ivermectin /kg bw, the mean concentrations of ivermectin in plasma and milk increased initially to reach at 2.8 day the maximum levels of 6.12 and 7.26 ppb, respectively (51). The drug could be detected in milk for 25 days postdosing, the total drug amount recovered over this period being estimated at 0.6% of the administered dose. This percentage is low compared with the 4% level determined in sheep (52) and 5.6% in cows (53). 

Metabolism studies showed that the major metabolites of the components of ivermectin in cattle, sheep, and rats were 24-hydroxymethyl compounds, whereas major metabolites in swine were 3-0-desmethyl compounds. Identification of the 24-hydroxymethyl metabolites has not been yet achieved in swine, whereas identification of Hie 3-O-desmetlryl metabolites has not been made possible in cattle or sheep (54, 55). Recent metabolism studies (56) in cattle, swine, and rats have indicated, however, diat the metabolism of avermectins was qualitatively similar for all three species. There were quantitative differences both between species and between compounds for a given species, but all three species produced... 

In addition, a total of 36 of 220 samples (16%) of trout contained residues of malachite green in the range 2-33 ppb a total of 41 of 409 salmon samples contained residues of ivermectin in the range 2-30 ppb. Although the MRL of 100 ppb set for bovine liver cannot be directly extrapolated to salmon, it is considered unlikely that, at the concentrations of ivermectin being determined in salmon, the ADI for this substance is being exceeded. There is therefore unlikely to be a consumer hazard arising from these residues. 

The effect of heating on aqueous solutions of ivermectin is difficult to study due to the very low solubility of the compound in water. Thus, the stability of ivermectin has been only investigated on incurred tissue samples. When a series of incurred pig and cattle muscle and liver samples and salmon muscle samples were subjected to various cooking processes, some loss of ivermectin was observed but the loss was associated with the leakage of the fat from the tissue samples... 

---